Glucagon-like peptide-1 analogues: a new way to quit smoking? (SKIP)-a structured summary of a study protocol for a randomized controlled study.

Sophia LengsfeldThilo BurkardAndrea MeienbergNica JeanlozDavid CoynelDeborah R VogtLars G HemkensBenjamin SpeichDavide ZanchiTobias E ErlangerMirjam Christ-CrainBettina Winzeler

Published in: Trials (2023)

ClinicalTrials.gov NCT03204396 . Registered on June 26, 2017.

Keyphrases

smoking cessation
molecular docking
replacement therapy
structure activity relationship
molecular dynamics simulations